LOADING
Comparing NVIDIA Corporation (NVDA) and Eli Lilly and Company (LLY) across the Technology and Health Care sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | NVDA | LLY |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $5.27T | -- |
| P/E Ratio | 27.6 | -- |
| Forward P/E | 24.1 | -- |
| PEG Ratio | 0.56 | -- |
| EPS | $7.90 | -- |
| Revenue Growth (YoY) | 105.9% | -- |
| Profit Margin | 63.7% | -- |
| Return on Equity | 117.2% | -- |
| Dividend Yield | 0.13% | -- |
| Beta | 2.22 | -- |
| 52-Week High | $236.00 | -- |
| 52-Week Low | $163.90 | -- |
| Volume | -- | -- |